Literature DB >> 15872188

Potential uptake and correlates of willingness to use a supervised smoking facility for noninjection illicit drug use.

Courtney L C Collins1, Thomas Kerr, Laura M Kuyper, Kathy Li, Mark W Tyndall, David C Marsh, Julio S Montaner, Evan Wood.   

Abstract

Many cities are experiencing infectious disease epidemics and substantial community harms as a result of illicit drug use. Although medically supervised smoking facilities (SSFs) remain untested in North America, local health officials in Vancouver are considering to prepare a submission to Health Canada for an exemption to open Canada's first SSF for evaluation. Reluctance of health policymakers to initiate a pilot study of SSFs may be due in part to outstanding questions regarding the potential uptake and community impacts of the intervention. This study was conducted to evaluate the prevalence and correlates of willingness to use an SSF among illicit drug smokers who are enrolled in the Vancouver Injection Drug Users Study. Participants who reported actively smoking cocaine, heroin, or methamphetamine who returned for follow-up between June 2002 and December 2002 were eligible for these analyses. Those who reported willingness to use an SSF were compared with those who were unwilling to use an SSF by using logistic regression analyses. Four hundred and forty-three participants were eligible for this study. Among respondents, 124 (27.99%) expressed willingness to attend an SSF. Variables that were independently associated with willingness to attend an SSF in multivariate analyses included sex-trade work (adjusted odds ratio [AOR]=1.85), crack pipe sharing (AOR=2.24), and residing in the city's HIV epicentre (AOR =1.64). We found that participants who demonstrated a willingness to attend an SSF were more likely to be involved in the sex trade and share crack pipes. Although the impact of SSFs in North America can only be quantified by scientific evaluation, these data indicate a potential for public health and community benefits if SSFs were to become available.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15872188      PMCID: PMC3456572          DOI: 10.1093/jurban/jti051

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  36 in total

1.  HIV-associated oral lesions; immunologic, virologic and salivary parameters.

Authors:  C E Barr; M R Lopez; A Rua-Dobles; L K Miller; U Mathur-Wagh; L R Turgeon
Journal:  J Oral Pathol Med       Date:  1992-08       Impact factor: 4.253

2.  Phenomenologic comparison of the idiopathic psychosis of schizophrenia and drug-induced cocaine and phencyclidine psychoses: a retrospective study.

Authors:  R B Rosse; J P Collins; M Fay-McCarthy; T N Alim; R J Wyatt; S I Deutsch
Journal:  Clin Neuropharmacol       Date:  1994-08       Impact factor: 1.592

Review 3.  Hepatitis C in asymptomatic blood donors.

Authors:  H J Alter; C Conry-Cantilena; J Melpolder; D Tan; M Van Raden; D Herion; D Lau; J H Hoofnagle
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

4.  Incidence and prevalence of hepatitis C among clients of a Brisbane methadone clinic: factors influencing hepatitis C serostatus.

Authors:  L A Selvey; M Denton; A J Plant
Journal:  Aust N Z J Public Health       Date:  1997-02       Impact factor: 2.939

5.  Identifying oral lesions associated with crack cocaine use.

Authors:  D A Mitchell-Lewis; J A Phelan; R B Kelly; J J Bradley; I B Lamster
Journal:  J Am Dent Assoc       Date:  1994-08       Impact factor: 3.634

6.  Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland.

Authors:  S A Villano; D Vlahov; K E Nelson; C M Lyles; S Cohn; D L Thomas
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

7.  From the Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.

Authors: 
Journal:  JAMA       Date:  1993-02-10       Impact factor: 56.272

8.  The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users.

Authors:  J Astemborski; D Vlahov; D Warren; L Solomon; K E Nelson
Journal:  Am J Public Health       Date:  1994-03       Impact factor: 9.308

9.  Crack cocaine smoking and oral sores in three inner-city neighborhoods.

Authors:  S Faruque; B R Edlin; C B McCoy; C O Word; S A Larsen; D S Schmid; J C Von Bargen; Y Serrano
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996-09

10.  Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.

Authors:  C Conry-Cantilena; M VanRaden; J Gibble; J Melpolder; A O Shakil; L Viladomiu; L Cheung; A DiBisceglie; J Hoofnagle; J W Shih
Journal:  N Engl J Med       Date:  1996-06-27       Impact factor: 91.245

View more
  10 in total

1.  "We need somewhere to smoke crack": An ethnographic study of an unsanctioned safer smoking room in Vancouver, Canada.

Authors:  Ryan McNeil; Thomas Kerr; Hugh Lampkin; Will Small
Journal:  Int J Drug Policy       Date:  2015-01-19

2.  Willingness to use an in-hospital supervised inhalation room among people who smoke crack cocaine in Vancouver, Canada.

Authors:  Sandra Cortina; Mary Clare Kennedy; Huiru Dong; Nadia Fairbairn; Kanna Hayashi; M-J Milloy; Thomas Kerr
Journal:  Drug Alcohol Rev       Date:  2018-06-05

3.  Modelling crack cocaine use trends over 10 years in a Canadian setting.

Authors:  Dan Werb; Kora Debeck; Thomas Kerr; Kathy Li; Julio Montaner; Evan Wood
Journal:  Drug Alcohol Rev       Date:  2010-05

4.  Supervised inhalation is an important part of supervised consumption services.

Authors:  Stacey Bourque; Em M Pijl; Erin Mason; Jill Manning; Takara Motz
Journal:  Can J Public Health       Date:  2019-02-06

5.  Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs.

Authors:  Kora DeBeck; Thomas Kerr; Kathy Li; Benedikt Fischer; Jane Buxton; Julio Montaner; Evan Wood
Journal:  CMAJ       Date:  2009-10-19       Impact factor: 8.262

6.  Public crack cocaine smoking and willingness to use a supervised inhalation facility: implications for street disorder.

Authors:  Kora DeBeck; Jane Buxton; Thomas Kerr; Jiezhi Qi; Julio Montaner; Evan Wood
Journal:  Subst Abuse Treat Prev Policy       Date:  2011-02-23

7.  A cost-benefit/cost-effectiveness analysis of an unsanctioned supervised smoking facility in the Downtown Eastside of Vancouver, Canada.

Authors:  Ehsan Jozaghi
Journal:  Harm Reduct J       Date:  2014-11-13

8.  Risky and rushed public crack cocaine smoking: the potential for supervised inhalation facilities.

Authors:  Pauline Voon; Lianping Ti; Huiru Dong; M-J Milloy; Evan Wood; Thomas Kerr; Kanna Hayashi
Journal:  BMC Public Health       Date:  2016-06-07       Impact factor: 3.295

9.  Peer-engagement and its role in reducing the risky behavior among crack and methamphetamine smokers of the Downtown Eastside community of Vancouver, Canada.

Authors:  Ehsan Jozaghi; Hugh Lampkin; Martin A Andresen
Journal:  Harm Reduct J       Date:  2016-06-08

10.  From opiates to methamphetamine: building new harm reduction responses in Jakarta, Indonesia.

Authors:  Rafaela Rigoni; Sara Woods; Joost J Breeksema
Journal:  Harm Reduct J       Date:  2019-12-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.